One of the most essential sectors and, after the outbreak of Covid-19, has become even more prominent is the health sector. If investors previously shied away from this sector because of their ignorance or because of the fact that startups in this sector were slow to reach the market and generate profits, now the opposite is true. Investors have realized that health is something essential, that it affects us all and that innovation and technology are the solution. Today at Intelectium we want to bring you closer to 7 new startups that we work hard with every day so that they can obtain funding to grow and bring their innovative solutions for our health to the market:
Innitius
Innitius is a health startup dedicated to the development of innovative devices based on torsion waves to improve women's health. Through “Fine Birth”, the first Innitius product, they can differentiate between a false and a true premature birth in less than 30 minutes. Dr. Guillermo Rus (Co-founder of Innitius) in 2007 began a theoretical research project on continuous mechanics, which became a novel patented sensor system that is capable of measuring changes in the consistency of a tissue with extremely high sensitivity. In 2012, the team began applying the knowledge of Dr. Guillermo Rus to the field of Gynecology and Obstetrics together with Francisca Molina (Co-founder of Innitus), creating the Biomechanics Group (IBS). In 2017, Innitius was constituted as a spinoff of the University of Granada (UGR) and the Public Health System of Andalusia (SAS), which was born as a result of several research projects that resulted in the Fine Birth device for the diagnosis of preterm birth.
Flomics
Flomics revolutionizes the way to diagnose a wide range of complex diseases, such as the diagnosis of colorectal cancer. Through a tool for the detection of complex diseases, a diagnosis is made of the patient using a blood sample, from which the patient's cRNA is extracted, which is then processed using machine learning algorithms. In this way, diseases can be detected even before the first symptoms appear, reducing the mortality and morbidity rate of patients. The tools used today to detect the vast majority of fatal diseases are the same as those used 50 years ago and, therefore, they are very invasive tools, which generate erroneous results, take a long time and, in addition, are very expensive. Flomics revolutionizes the detection of these diseases through a blood sample and “machine learning” technology. In up to 3 days, Flomics obtains a diagnosis with high reliability and without being so invasive or costly.Sycai TechnologiesLuci Health SolutionsInsulclockWalden MedicalOnira Research
